Evidence map›Paper›PMID 37932311›Full record

ArticleNature communications2023

Evolutionary design of explainable algorithms for biomedical image segmentation.

Kévin Cortacero, Brienne McKenzie, Sabina Müller, Roxana Khazen, Fanny Lafouresse, Gaëlle Corsaut, Nathalie Van Acker, François-Xavier Frenois, Laurence Lamant, Nicolas Meyer and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 4 countries.

Kévin CortaceroInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France.ORCID 0000-0003-3685-7658
Brienne McKenzieInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France.
Sabina MüllerInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France.
Roxana KhazenInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France.
Fanny LafouresseInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France.ORCID 0000-0001-6572-8631
Gaëlle CorsautInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France.
Nathalie Van AckerDepartment of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse (IUCT), Toulouse, France.
François-Xavier FrenoisDepartment of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse (IUCT), Toulouse, France.
Laurence LamantDepartment of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse (IUCT), Toulouse, France.
Nicolas MeyerDepartment of Dermatology, IUCT, Toulouse, France.
Béatrice VergierService de Pathologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Dennis G WilsonUniversity of Toulouse - Institut de Recherche en Informatique de Toulouse (IRIT) - UMR5505, Artificial and Natural Intelligence Toulouse Institute, Toulouse, France.
Hervé LugaUniversity of Toulouse - Institut de Recherche en Informatique de Toulouse (IRIT) - UMR5505, Artificial and Natural Intelligence Toulouse Institute, Toulouse, France.
Oskar StauferKennedy Institute of Rheumatology (KIR), Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Michael L DustinKennedy Institute of Rheumatology (KIR), Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.ORCID 0000-0003-4983-6389
Salvatore Valitutti *Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Toulouse, France. salvatore.valitutti@inserm.fr.ORCID 0000-0002-6432-4421
Sylvain Cussat-Blanc *University of Toulouse - Institut de Recherche en Informatique de Toulouse (IRIT) - UMR5505, Artificial and Natural Intelligence Toulouse Institute, Toulouse, France. sylvain.cussat-blanc@irit.fr.ORCID 0000-0003-1360-1932
Centre National de la Recherche Scientifique · FRInstitut universitaire du cancer de Toulouse Oncopole · FRUniversité Toulouse III - Paul Sabatier · FRUniversity of Oxford · GBUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An unresolved issue in contemporary biomedicine is the overwhelming number and diversity of complex images that require annotation, analysis and interpretation. Recent advances in Deep Learning have revolutionized the field of computer vision, creating algorithms that compete with human experts in image segmentation tasks. However, these frameworks require large human-annotated datasets for training and the resulting "black box" models are difficult to interpret. In this study, we introduce Kartezio, a modular Cartesian Genetic Programming-based computational strategy that generates fully transparent and easily interpretable image processing pipelines by iteratively assembling and parameterizing computer vision functions. The pipelines thus generated exhibit comparable precision to state-of-the-art Deep Learning approaches on instance segmentation tasks, while requiring drastically smaller training datasets. This Few-Shot Learning method confers tremendous flexibility, speed, and functionality to this approach. We then deploy Kartezio to solve a series of semantic and instance segmentation problems, and demonstrate its utility across diverse images ranging from multiplexed tissue histopathology images to high resolution microscopy images. While the flexibility, robustness and practical utility of Kartezio make this fully explicable evolutionary designer a potential game-changer in the field of biomedical image processing, Kartezio remains complementary and potentially auxiliary to mainstream Deep Learning approaches.

Indexed as

AlgorithmsImage Processing, Computer-AssistedBiological EvolutionHumansMicroscopySemantics

Identifiers

PMID37932311
PMCPMC10628266
OpenAlexW4388419173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.